Oral Abstract Session: Islet Transplantation: Addressing innate inflammation
Friday October 27, 2023 from 07:30 to 08:25
Indigo A
Moderators
Lectures
-
201.1 Co-engineering pancreatic islets with novel forms of thrombomodulin and CD47 as an effective means of mitigating instant blood-mediated inflammatory reactionHaval Shirwan, United States
-
201.2 No differences in long-term diabetes outcomes with etanercept or alpha-1 antitrypsin treatment in total pancreatectomy and islet autotransplantation: A randomized controlled pilot studyDr. Tasneem R Abdel-Karim, United States
-
201.3 Neutralization of HMGB1 released from pancreatic islet via surface camouflage having glycol chitosan-glycyrrhizin conjugateMiss ChaeRim Yoo, Korea
-
201.4 Islet stressomes released during isolation and in response to inflammation may affect outcomes in islet auto-transplantationDr. Mazhar A Kanak, United States
-
201.5 TNF-alpha blockade during islet transplantation in immunosuppressed recipients: a study on in vitro, clinical, and CITR registry-derived dataMs. Cyril P Landstra, Netherlands